Drug General Information
Drug ID
D0YM7U
Former ID
DCL000627
Drug Name
Rituxan Hemotalogy/oncology
Drug Type
Antibody
Indication Non-hodgkin's lymphoma [ICD10:C85] Approved [544126]
Company
Genentech
Target and Pathway
Target(s) B-lymphocyte antigen CD20 Target Info [550797]
KEGG Pathway Hematopoietic cell lineage
References
Ref 544126Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin's Lymphoma. P T. 2010 March; 35(3): 148-157.
Ref 550797Clinical pipeline report, company report or official report of Genentech (2009).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.